Validation of the Barthel Index as a Predictor of In-Hospital Mortality among COVID-19 Patients

Author:

Mateos-Arroyo Julio Alberto1ORCID,Zaragoza-García Ignacio23ORCID,Sánchez-Gómez Rubén24ORCID,Posada-Moreno Paloma24,Ortuño-Soriano Ismael24ORCID

Affiliation:

1. Department of Pneumology, Hospital General Nuestra Señora del Prado, 45600 Talavera de la Reina, Spain

2. Department of Nursing, Faculty of Nursing, Physiotherapy and Podology, University Complutense of Madrid, 28040 Madrid, Spain

3. Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain

4. FIBHCSC, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain

Abstract

In order to predict the high mortality due to COVID-19, simple, useful and remote instruments are required. To assess the validity of the baseline Barthel Index score as a predictor of in-hospital mortality among COVID-19 patients, a validation study of a clinical prediction tool in a cohort of patients with COVID-19 was conducted. The primary variable was mortality and the Barthel Index was the main explanatory variable. Demographic, clinical and laboratory variables were collected. Other mortality predictor scores were also assessed: Pneumonia Severity Index, CURB-65 and A-DROP. The Receiver Operating Characteristic Area under the Curve (ROC AUC), sensitivity and specificity were calculated for both the Barthel Index and the other predictor scores. An analysis of the association between the main variables was conducted, adjusting by means of three multivariate models. Three hundred and twelve patients were studied. Mortality was 16.4%. A mortality Odds Ratio (OR) of 5.95 was associated with patients with a Barthel Index ≤ 90. The model number 3 was developed to predict in-hospital mortality before COVID-19 infection occurs. It exhibits an OR of 3.44, a ROC AUC of 0.792, a sensitivity of 74.5% and a specificity of 73.9%. The Baseline Barthel Index proved useful in our population as a predictor of in-hospital mortality due to COVID-19.

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference44 articles.

1. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle;Lu;J. Med. Virol.,2020

2. World Health Organization (2023, March 06). Archived: WHO Timeline—COVID-19. Available online: https://www.who.int/news/item/27-04-2020-who-timeline---covid-19.

3. Adhanom Ghebreyesus, T. (2023, March 06). WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. World Health Organization. Available online: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

4. PAHO/WHO (2023, March 06). Epidemiological Update: Coronavirus Disease (COVID-19). Available online: https://iris.paho.org/bitstream/handle/10665.2/54717/EpiUpdate21August2021_eng.pdf?sequence=1&isAllowed=y.

5. World Health Organization (2023, March 06). COVID-19—China. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON233.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3